Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2

Abstract

Angiotensin-converting enzyme 2 (ACE2), also known as peptidyl-dipeptidase A, belongs to the dipeptidyl carboxydipeptidases family has emerged as a potential antiviral drug target against SARS-CoV-2. Most of the ACE2 inhibitors discovered till now are chemical synthesis; suffer from many limitations related to stability and adverse side effects. However, natural, and selective ACE2 inhibitors that possess strong stability and low side effects can be replaced instead of those chemicals' inhibitors. To envisage structurally diverse natural entities as an ACE2 inhibitor with better efficacy, a 3D structure-based-pharmacophore model (SBPM) has been developed and validated by 20 known selective inhibitors with their correspondence 1166 decoy compounds. The validated SBPM has excellent goodness of hit score and good predictive ability, which has been appointed as a query model for further screening of 11,295 natural compounds. The resultant 23 hits compounds with pharmacophore fit score 75.31 to 78.81 were optimized using in-silico ADMET and molecular docking analysis. Four potential natural inhibitory molecules namely D-DOPA (Amb17613565), L-Saccharopine (Amb6600091), D-Phenylalanine (Amb3940754), and L-Mimosine (Amb21855906) have been selected based on their binding affinity (−7.5, −7.1, −7.1, and −7.0 kcal/mol), respectively. Moreover, 250 ns molecular dynamics (MD) simulations confirmed the structural stability of the ligands within the protein. Additionally, MM/GBSA approach also used to support the stability of molecules to the binding site of the protein that also confirm the stability of the selected four natural compounds. The virtual screening strategy used in this study demonstrated four natural compounds that can be utilized for designing a future class of potential natural ACE2 inhibitor that will block the spike (S) protein dependent entry of SARS-CoV-2 into the host cell.

Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches

“…The complex structure of the selected vaccine-receptor complex candidate was evaluated using 100 ns molecular dynamic simulations (MDS) to evaluate their binding stability to the desired protein to the active site cavity of the protein [ 64 , 65 ]. The MDS of the receptor–ligand complex was performed using the ‘Desmond v6.3 Program’ in Schrödinger 2020-3 under Linux framework to evaluate the thermodynamic stability of the receptor–ligand complex [ 66 , 67 ].…”

Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach

“…The complex structure of the selected candidate compounds was evaluated using 50 ns molecular dynamic simulations (MDS) to evaluate their binding stability to the desired protein to the active site cavity of the protein [ 66 ]. The MDS of the receptor-ligand complex was performed using the ‘Desmond v6.3 Program' in Schrödinger 2020-3 under Linux framework to evaluate the thermodynamic stability of the receptor-ligand complex [ 67 ].…”

Toward the Identification of Natural Antiviral Drug Candidates against Merkel Cell Polyomavirus: Computational Drug Design Approaches

“…Phytochemicals from a variety of medicinal plants were retrieved from the database and prepared by applying OPLS_2005 as a force field. The Epik ionization tool of Schrödinger Suite was utilized to obtain the ionization state of the compound, where the pH was set within the range of 7 ± 2 [ 67 ]. All possible deprotonated and ionization states along with their tautomers, stereochemistry, and ring conformations of the compound were also determined during the ligand preparation process.…”

“…MD simulations were conducted using the Desmond v3.6 program in Schrödinger to determine the stable interactions of the ligands to the binding pockets of the receptors [ 67 ]. The stability of the selected compounds in binding the target protein was determined through 250 ns MD simulations.…”